JP Morgan Chase
ETON icon

JP Morgan Chase’s Eton Pharmaceutcials ETON Stock Holding History

JP Morgan Chase’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.04M Buy
191,635
+21,759
+13% +$638K ﹤0.01% 3128
2026
Q1 		$3.84M Sell
169,876
-15,563
-8% -$272K ﹤0.01% 3570
2025
Q4 		$3.14M Sell
185,439
-165,978
-47% -$2.92M ﹤0.01% 3727
2025
Q3 		$7.64M Buy
351,417
+108,837
+45% +$1.81M ﹤0.01% 2960
2025
Q2 		$3.46M Buy
242,580
+129,467
+114% +$2.05M ﹤0.01% 3484
2025
Q1 		$1.47M Buy
113,113
+61,152
+118% +$924K ﹤0.01% 4083
2024
Q4 		$692K Buy
51,961
+51,238
+7,087% +$520K ﹤0.01% 4869
2024
Q3 		$4.34K Buy
+723
New +$3.06K ﹤0.01% 6516
2024
Q2 		– Sell
-19,155
Closed -$71.8K – 7457
2024
Q1 		$71.8K Buy
+19,155
New +$83.6K ﹤0.01% 5802
2023
Q3 		– Sell
-5,911
Closed -$20.6K – 7531
2023
Q2 		$20.6K Buy
+5,911
New +$21.7K ﹤0.01% 5910
2022
Q4 		– Sell
-13,278
Closed -$28K – 6661
2022
Q3 		$28K Buy
13,278
+9,153
+222% +$22.8K ﹤0.01% 5711
2022
Q2 		$11K Sell
4,125
-20,148
-83% -$67.6K ﹤0.01% 6014
2022
Q1 		$106K Buy
+24,273
New +$95.5K ﹤0.01% 5477
2021
Q3 		– Sell
-153
Closed -$1K – 6559
2021
Q2 		$1K Sell
153
-6,251
-98% -$46.3K ﹤0.01% 6245
2021
Q1 		$47K Sell
6,404
-24,864
-80% -$212K ﹤0.01% 5542
2020
Q4 		$254K Buy
31,268
+21,283
+213% +$164K ﹤0.01% 4716
2020
Q3 		$78K Sell
9,985
-1,186
-11% -$8.1K ﹤0.01% 4806
2020
Q2 		$61K Buy
+11,171
New +$55.5K ﹤0.01% 4758

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $6.92B AUM 24.7% 1-Year Est. Return

JP Morgan Chase's ETON Position: Q2 2026 in Review

JP Morgan Chase increased its Eton Pharmaceutcials (ETON) stake by 13% in Q2 2026, buying an estimated $638K and bringing the position to 191,635 shares worth $7.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3128.

JP Morgan Chase first reported a position in ETON in Q2 2020 and has held it in 18 quarters since. The position peaked at $7.64M in Q3 2025. 164 funds tracked by Wall St. Rank hold ETON as of Q2 2026.

  • JP Morgan Chase held 191,635 shares of Eton Pharmaceutcials worth $7.04M as of Q2 2026.
  • JP Morgan Chase bought 21,759 Eton Pharmaceutcials shares in Q2 2026, an estimated $638K.
  • Eton Pharmaceutcials made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #3128 holding.
  • JP Morgan Chase first reported a position in Eton Pharmaceutcials in Q2 2020 and has held it in 18 quarters since.
  • JP Morgan Chase's Eton Pharmaceutcials position peaked at $7.64M in Q3 2025.
  • 164 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.